Matthew Robbins, MD: Experience Adjusting to COVID-19 in Migraine Care


The director of the Neurology Residency Program at Weill Cornell Medicine details his first-hand experience working in the epicenter of the COVID-19 pandemic and how his department adapted.

“The way this has impacted both our patients and the way we care for them has been extraordinary and unpredictable.”

At the 2020 American Headache Society Annual Meeting, Matthew Robbins, MD, presented his experience on how COVID-19 impacted headache and neurological care in New York, as well as giving an overview of emerging clinical phenomenology of headache and COVID-19 to provide perspective from him and his colleagues.

The assistant professor of neurology and director of the Neurology Residency Program at Weill Cornell Medicine noted the substantial changes and adjustments that needed to be made on the fly at all levels throughout the pandemic. He claims that everyone is thrusted into uncomfortable positions but being able to adapt under the pressure has shown the true colors of those on the front lines.

In an interview with NeurologyLive, Robbins discusses how his team of clinicians continued to adjust as the pandemic continued to increase, and why having an open mind has been helped the situation.

Related Videos
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
Anton P. Porsteinsson, MD
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN
Tarun Singhal, MD, MBBS
Jessica Ailani, MD
© 2024 MJH Life Sciences

All rights reserved.